Skip to main content
Livermore
Livermore
ZHEN

Orchard Therapeutics plc

ORTXDelisted Jan 24, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001748907

Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.

13F holders, Q4 2022

Institutional positions in Orchard Therapeutics plc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
47
+2 vs. Q3 2022
Shares held
43.9M
−4.89M (−10.0%) vs. Q3 2022
Total value
$16.3M
−$8.12M (−33.3%) vs. Q3 2022
New holders
8
10 more added
Sold out
6
10 more reduced

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ORTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 47 institutions
Q1 2021: 83 institutionsQ2 2021: 85 institutionsQ3 2021: 79 institutionsQ4 2021: 72 institutionsQ1 2022: 61 institutionsQ2 2022: 50 institutionsQ3 2022: 47 institutionsQ4 2022: 47 institutionsQ1 2023: 35 institutionsQ2 2023: 33 institutionsQ3 2023: 32 institutionsQ4 2023: 47 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2022: $16.3M
Q1 2021: $546.3MQ2 2021: $350.8MQ3 2021: $167.4MQ4 2021: $84.6MQ1 2022: $38.9MQ2 2022: $30.2MQ3 2022: $24.7MQ4 2022: $16.3MQ1 2023: $31.2MQ2 2023: $26.2MQ3 2023: $46.9MQ4 2023: $122.0MQ1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ORTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 202347$122.0M
Q3 202332$46.9M
Q2 202333$26.2M
Q1 202335$31.2M
Q4 202247$16.3M
Q3 202247$24.7M
Q2 202250$30.2M
Q1 202261$38.9M
Q4 202172$84.6M
Q3 202179$167.4M
Q2 202185$350.8M
Q1 202183$546.3M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Orchard Therapeutics plc; share changes are against Q3 2022.

Institutions holding ORTX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada9$00.00%00.0%Unchanged
CWM, LLC883$00.00%+883New
Armstrong Advisory Group, Inc50$190.00%+50New
Mine & Arao Wealth Creation & Management, LLC.100$370.00%00.0%Unchanged
Beaird Harris Wealth Management, LLC120$450.00%00.0%Unchanged
Concord Wealth Partners1,000$3710.00%+1,000New
Citigroup Inc1,100$4080.00%−81−6.9%Reduced
Barclays PLC2,000$7420.00%00.0%Unchanged
Advisor Group Holdings, Inc.7,124$3.09K0.00%+5,145+260.0%Added
Connecticut Wealth Management, LLC10,000$3.71K0.00%00.0%Unchanged
HighTower Advisors, LLC12,000$4.00K0.00%00.0%Unchanged
Ironsides Asset Advisors, LLC10,581$4.00K0.00%−70−0.7%Reduced
Tower Research Capital LLC (TRC)9,654$4.00K0.00%+8,901+1,182.1%Added
Virtu Financial LLC12,015$4.00K0.00%+12,015New
Lane Generational LLC10,828$4.02K0.01%+10,828New
Oppenheimer & Co Inc11,500$4.27K0.00%−200−1.7%Reduced
Wells Fargo & Company12,500$4.64K0.00%00.0%Unchanged
IPG Investment Advisors LLC14,100$5.23K0.00%00.0%Unchanged
Holderness Investments Co14,730$5.46K0.00%00.0%Unchanged
StoneX Group Inc.15,000$5.57K0.00%+15,000New
UBS Group AG16,844$6.23K0.00%+13,035+342.2%Added
Bank of America Corp18,301$6.79K0.00%−53,202−74.4%Reduced
Goldman Sachs Group Inc20,223$7.50K0.00%+20,223New
Two Sigma Advisers, LP21,100$7.83K0.00%+1,600+8.2%Added
Spears Abacus Advisors LLC21,145$7.84K0.00%00.0%Unchanged
Banque Cantonale Vaudoise24,000$8.00K0.00%00.0%Unchanged
Two Sigma Investments, LP21,905$8.13K0.00%−14,686−40.1%Reduced
Geode Capital Management, LLC26,079$9.00K0.00%00.0%Unchanged
Two Sigma Securities, LLC25,359$9.41K0.00%+11,534+83.4%Added
Allegheny Financial Group LTD28,750$10.7K0.00%+12,000+71.6%Added
Jane Street Group, LLC75,643$28.1K0.00%+29,690+64.6%Added
Forefront Analytics, LLC164,894$61.2K0.03%+64,853+64.8%Added
JPMorgan Chase & Co217,166$81.0K0.00%−5,383−2.4%Reduced
Cormorant Asset Management, LP256,649$95.0K0.01%00.0%Unchanged
Morgan Stanley291,411$108.1K0.00%−6,069−2.0%Reduced
Millennium Management LLC319,516$119.0K0.00%−39,353−11.0%Reduced
Mariner, LLC630,975$234.0K0.00%+630,975New
Acadian Asset Management LLC1,202,604$445.0K0.00%+104,010+9.5%Added
Artal Group S.A.1,803,858$669.0K0.04%00.0%Unchanged
Renaissance Technologies LLC1,842,280$683.0K0.00%−693,159−27.3%Reduced
Tang Capital Management LLC2,000,000$742.0K0.11%00.0%Unchanged
Citadel Advisors LLC2,294,315$851.2K0.00%+3,973+0.2%Added
Deerfield Management Company, L.P. (Series C)3,161,707$1.17M0.02%−3,787,709−54.5%Reduced
Temasek Holdings (Private) Ltd4,319,049$1.60M0.01%00.0%Unchanged
CHI Advisors LLC7,987,396$2.96M0.79%00.0%Unchanged
Federated Hermes, Inc.8,401,687$3.12M0.01%00.0%Unchanged
FMR LLC8,611,375$3.19M0.00%00.0%Unchanged
BlackRock Inc.0$00.00%−712,001−100.0%Sold out
UBS Oconnor LLC0$00.00%−432,978−100.0%Sold out
Verition Fund Management LLC0$00.00%−50,000−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−33,717−100.0%Sold out
Running Point Capital Advisors, LLC0$00.00%−10,000−100.0%Sold out
Simplex Trading, LLC0$00.00%−1,870−100.0%Sold out
Strategic Wealth Advisors Group, LLC––––Not filed
American Portfolios Advisors––––Not filed